China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
China Resources Pharmaceutical Group Ltd. has entered into a new strategic cooperation agreement with CR Leasing, effective from January 2025 to December 2027. This deal allows the company to leverage financial services from CR Leasing, including leasing and consultancy, under competitive market terms. The transactions are classified as connected transactions but are exempt from requiring independent shareholder approval.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Amazon (NASDAQ:AMZN) Carries on With Grocery Store Plans
- Ford (NYSE:F) Faces Multiple Product Recalls
- ‘Favorable Trends,’ Says Top Investor About Super Micro Computer Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
